Recently, researchers have identified a unique combination of bromelain and acetylcysteine (BromAc)[1,2,3,4,5,6,7,8,9 ] that has the potential to inactivate SARS-CoV-2 synergistically.
Combining these two compounds is an interesting and effective way to tackle the current madness about the so-called (artificially caused) COVID pandemic.
Bromelain enzyme is known to have synergistic action against glycoproteins by breakage of glycosidic linkages and disulfide bonds.
Acetylcysteine, on the other hand, is an amino acid derivative that has shown the ability to modulate protein structure and induce the formation of disulfide bonds.
Bromelain and acetylcysteine form a strong bond with the spike proteins of SARS-CoV-2 and prevent them from binding to human cells, thus inactivating the "virus". In the case of bromelain and acetylcysteine, the combination has shown promise in its potential to inactivate SARS-CoV-2.
The ability of N-acetylcysteine and bromelain to work together to fight off viruses is an exciting prospect.As it is stated in the conclusion of the study "BromAc may be an effective therapeutic agent for early SARS-CoV-2 infection, despite mutations, and even have potential as a prophylactic in people at high risk of infection."